La Madeleine, France

Aurélie Tasiemski

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université Des Sciences Et Technologies De Lille. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aurélie Tasiemski. Retrieved from https://idiyas.com/inventor/aurélie-tasiemski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aurélie Tasiemski - Innovator in Antimicrobial Peptides

Introduction

Aurélie Tasiemski is an inventor based in Lille, France. He has made significant contributions to the field of antimicrobial peptides. His work focuses on the development of peptides that exhibit antimicrobial properties, which are crucial in combating bacterial infections.

Latest Patent Applications

Aurélie Tasiemski's notable patent application is titled "Antimicrobial Peptides, Variants and Chemical Analogues Thereof and Their Uses." This application describes a peptide of 20 amino acids, named Michelicin, with the sequence RVCVRICRNGRCYRRCWNT. This peptide is derived from a longer precursor containing a BRICHOS domain from a marine worm. The structure of Michelicin includes several cysteines that form disulfide bridges, providing stability in salt conditions. The application also discusses various derivatives and analogues that have been produced, demonstrating antimicrobial activity against a wide range of bacteria. Additionally, it covers nucleic acid sequences encoding these peptides, pharmaceutical compositions, and their potential uses as drugs, preservatives, and disinfectants.

Conclusion

Aurélie Tasiemski's innovative work in antimicrobial peptides highlights the importance of developing new solutions to address bacterial infections. His research has the potential to lead to significant advancements in medical and pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…